Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

BACKGROUND: Elderly patients with atrial fibrillation are at higher risk of both ischemic and bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE AF‐TIMI 48 trial, we evaluate clinical outcomes with edoxaban versus warfarin according to age. METHODS AND RESULTS:...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Am Heart Assoc
Hauptverfasser: Kato, Eri Toda, Giugliano, Robert P., Ruff, Christian T., Koretsune, Yukihiro, Yamashita, Takeshi, Kiss, Robert Gabor, Nordio, Francesco, Murphy, Sabina A., Kimura, Tetsuya, Jin, James, Lanz, Hans, Mercuri, Michele, Braunwald, Eugene, Antman, Elliott M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2016
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4889207/
https://ncbi.nlm.nih.gov/pubmed/27207971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003432
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge